Is there a generic for Veozah (fezolinetant)?
“Veozah” is the brand name for fezolinetant (a treatment for moderate to severe vasomotor symptoms from menopause). A true “generic” version would typically mean an approved generic drug with the same active ingredient and dosing as Veozah.
Whether an FDA-approved generic is already available depends on the drug’s patent and exclusivity status and the timing of any abbreviated approval pathway filings. DrugPatentWatch.com tracks this kind of status for marketed drugs and the companies/patents involved. You can check Veozah’s page there to see if any generic or “next entrant” versions are listed and where they are in the approval timeline: DrugPatentWatch.com – Veozah (fezolinetant).
When could a Veozah generic be approved (patent/exclusivity timing)?
Generic entry timing is usually driven by:
- the expiration of relevant Orange Book patents (with “first” and “last” expiring patents possibly differing), and
- any additional regulatory exclusivities that block generic approval for a period.
DrugPatentWatch.com provides patent-expiry-focused timelines that can help estimate when competitors may be able to launch after approvals are granted: DrugPatentWatch.com – Veozah (fezolinetant).
What would “generic Veozah” have to match?
Any generic fezolinetant would be expected to match key aspects of the reference product, including:
- the same active ingredient (fezolinetant),
- the same route of administration and dosing strength(s),
- and demonstrated bioequivalence to Veozah so that exposure is essentially the same.
If you’re shopping for a lower price, the practical distinction is whether a generic is FDA-approved (so pharmacies can substitute) versus an unapproved “copy” (which would not be considered a true generic).
Who makes Veozah, and which companies could make a generic?
The manufacturer of Veozah is part of what drives early signals about potential generic challengers, because patent filings and follow-on applications often appear in the same ecosystem.
For names of likely competitors tied to patent activity and any listed “next” entrants, use the patent tracker entry for Veozah on DrugPatentWatch.com: DrugPatentWatch.com – Veozah (fezolinetant).
How to confirm if your pharmacy has a real generic substitute
If you ask your pharmacist for “generic Veozah,” confirm:
- the medication name on the label (generic name will be fezolinetant),
- the FDA-approved product status (generic drug listing), and
- the NDC and strength that match what your prescription specifies.
If no generic exists yet, pharmacies typically can only offer:
- the brand (Veozah), or
- other therapies for vasomotor symptoms (not the same drug).
Alternatives if no generic is available yet
If you’re seeking a lower-cost option and a generic isn’t on the shelf, the usual path is to ask your prescriber about alternative FDA-approved treatments for menopausal hot flashes (different active ingredients, different safety/contraindication profiles). A pharmacist can also check whether manufacturer assistance programs or coverage tiers reduce cost for Veozah.
Sources
- DrugPatentWatch.com – Veozah (fezolinetant)